Home › Mylan: Outperformed S&P 500 Since June, And Shows No Signs Of Slowing
 

Keywords :   


Mylan: Outperformed S&P 500 Since June, And Shows No Signs Of Slowing

2015-01-22 16:03:15| Biotech - Topix.net

Mylan has shown alpha returns over the past year, beating the S&P 500 by approximately 4% in the past four months. The outlook for the drug device combination products industry is expected to grow at a CAGR rate of 7.9% through to 2019.

Tags: of june shows signs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
07.11Hurricane Rafael Graphics
07.11Hurricane Rafael Wind Speed Probabilities Number 14
07.11Hurricane Rafael Forecast Discussion Number 14
07.11Hurricane Rafael Forecast Advisory Number 14
07.11Hurricane Rafael Public Advisory Number 14
07.11Tropical Depression Fourteen-E Graphics
07.11Tropical Depression Fourteen-E Forecast Discussion Number 3
07.11Tropical Depression Fourteen-E Wind Speed Probabilities Number 3
More »